Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2Liver Failure, Acute 1Hepatitis B 1Fibrosis 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1115Gemcitabine 1058Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 678Radiotherapy 560Cetuximab 482pembrolizumab 437Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 280Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 223sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Carboplatin 191

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
adefovir dipivoxil × Gastrointestinal × Clear all
NCT00059267 2024-11-15

Prevention of Recurrent Hepatitis B After Liver Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed
317 enrolled
Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Failure, Acute

NCT00455091 2017-04-28

A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma

National Health Research Institutes, Taiwan

Terminated
117 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡